English | Español

Boehringer-Ingelheim
Carol Ostrow | Dec 15, 2017

Boehringer Ingelheim collaborations yield vaccine technology, cancer treatments
Ruth de Jauregui | Jun 14, 2017

Boehringer Ingelheim, Eli Lilly to collaborate in trial of empagliflozin for chronic kidney disease
Gene Johnson | Feb 25, 2017

Combination therapy targets lung cancer
Carol Ostrow | Feb 19, 2017

Partnership spurs efforts against COPD
Amanda Rupp | Jun 28, 2016

Boehringer Ingelheim board of managing directors introduces new member
Amanda Rupp | Jun 5, 2016

Boehringer Ingelheim, Inventiva collaborate for idiopathic pulmonary fibrosis treatments
Amanda Rupp | May 31, 2016

Boehringer Ingelheim to increase HIV/AIDS medication access
Amanda Rupp | May 25, 2016

BioMed X, Boehringer Ingelheim partner for psychiatric treatments

Trending
+ Technology/Innovation
Patient Daily | May 8, 2025

Medfluence attends 2025 Annual Clinical Assembly as only strategic marketing firm
+ Technology/Innovation
Patient Daily | May 7, 2025

OTO Forum 2025 highlights innovation in ENT
+ Pharmaceuticals
Patient Daily | May 8, 2025

Pacific Research Institute CEO: Hospitals are leveraging 340B's 'perverse incentives to enrich themselves'
+ Pharmaceuticals
Patient Daily | May 8, 2025

National Library of Medicine says compounded drugs like GLP-1 offer tailored alternatives to FDA-approved treatments